Victor Moyo
Hoofd Techniek/Wetenschap/O&O bij TRAWS PHARMA, INC.
Profiel
Victor Moyo is currently the Chief Medical Officer at Traws Pharma, Inc. since 2023 and at OncoPep, Inc. since 2022.
He holds a doctorate degree from the University of Zimbabwe.
Actieve functies van Victor Moyo
Bedrijven | Functie | Begin |
---|---|---|
TRAWS PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 24-10-2023 |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Corporate Officer/Principal | 01-05-2022 |
Opleiding van Victor Moyo
University of Zimbabwe | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TRAWS PHARMA, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |